脑老化的代谢组学特征:多模态与遗传研究
该研究整合英国生物银行多模态神经影像、血浆代谢组学与基因组数据,用1079个影像衍生表型在4333名健康参与者中训练脑龄预测模型,LASSO模型表现最佳(平均绝对误差=3.26年,R²=0.68)。在37458人中估计脑龄差,21780人关联分析发现9种血浆代谢物与脑龄差显著相关,葡萄糖效应最强(β=0.32,P=9.90×10⁻¹²),并提示葡萄糖加速脑老化的潜在因果作用。
要点
- 葡萄糖与脑龄差正相关最强(β=0.32,P=9.90×10⁻¹²),孟德尔随机化支持其潜在因果作用。
- 血浆葡萄糖升高与七种脑部疾病正相关,与认知、运动功能及心理健康结局负相关。
- 较高葡萄糖浓度与80个皮层、皮层下及小脑区域脑体积减小相关。
核心结论
- 葡萄糖代谢可能是脑老化中可干预的通路,对维持终身脑健康的早期干预策略有启示。
研究设计与样本
- 整合英国生物银行多模态神经影像、血浆代谢组学与基因组数据,用1079个影像衍生表型在4333名健康参与者中训练并验证脑龄预测机器学习模型。
主要发现
- LASSO回归模型脑龄预测表现最佳,平均绝对误差=3.26年,R²=0.68,并在37458名参与者中估计脑龄差。
- 21780人关联分析经Bonferroni校正后识别出9种血浆代谢物与脑龄差显著相关,葡萄糖效应最强(β=0.32,P=9.90×10⁻¹²)。
- 全基因组关联研究识别出392个与脑龄差相关的单核苷酸多态性(P<5×10⁻⁸),两样本孟德尔随机化支持葡萄糖加速脑老化的潜在因果作用。
- 血浆葡萄糖升高与七种脑部疾病正相关,包括全因痴呆、阿尔茨海默病、血管性痴呆、帕金森病、卒中、抑郁和焦虑,并与认知表现、运动功能和心理健康结局负相关。
- 较高葡萄糖浓度与80个皮层、皮层下及小脑区域脑体积减小相关。
关键数值与推荐
- 脑龄预测模型以平均绝对误差=3.26年、R²=0.68为最佳性能指标。
- 代谢物与脑龄差关联采用Bonferroni校正,葡萄糖效应为β=0.32,P=9.90×10⁻¹²。
- 全基因组关联研究采用P<5×10⁻⁸为显著性阈值,识别392个相关单核苷酸多态性。
临床怎么用
- 临床上可将血浆葡萄糖作为脑老化风险的代谢标志物进行监测,尤其对痴呆、抑郁和焦虑等脑部疾病高风险人群。
- 针对葡萄糖代谢的早期干预可能有助于延缓脑老化并降低相关脑部疾病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accelerated brain aging is increasingly recognized as a transdiagnostic risk factor for neuropsychiatric and neurodegenerative disorders, yet its metabolic underpinnings remain poorly understood. Here we integrated multimodal neuroimaging (MRI), plasma metabolomics, and genomic data from the UK Biobank to identify metabolic markers of brain aging and evaluate their causal relevance. Using 1079 imaging-derived phenotypes (IDPs) from 4333 healthy participants, we trained and validated machine learning models for brain age prediction, with a least absolute shrinkage and selection operator (LASSO) regression model achieving the best performance (mean absolute error = 3.26 years, R² = 0.68). Brain age gap (BAG) was then estimated in 37,458 participants. Association analyses in 21,780 individuals identified nine plasma metabolites significantly linked to BAG after Bonferroni correction, with glucose showing the strongest effect (β = 0.32, P = 9.90 × 10⁻¹²). Genome-wide association studies (GWAS) identified 392 BAG-associated single-nucleotide polymorphisms (SNPs) (P < 5 × 10⁻⁸), and two-sample Mendelian randomization (MR) provided evidence supporting a potential causal role of glucose in accelerating brain aging. Clinically, elevated plasma glucose was positively associated with seven brain disorders, including all-cause dementia, Alzheimer's disease, vascular dementia, Parkinson's disease, stroke, depression, and anxiety, and negatively associated with cognitive performance, movement function, and mental health outcomes. Higher glucose concentrations were also associated with reduced regional brain volumes across 80 cortical, subcortical, and cerebellar regions. These findings implicate glucose metabolism as a modifiable pathway in brain aging, with implications for early intervention strategies aimed at preserving brain health across the lifespan.
引用
- Li Z, Miao Y, Zhang X, et al. Metabolomic signatures of brain aging: A multimodal and genetic study. Mol Psychiatry. 2026. PMID: 42337012. doi:10.1038/s41380-026-03703-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。